The AI Revolution Meets America's Measles Regression
America is spending billions teaching machines to solve our hardest problems while struggling to preserve a victory over measles.
The year 2026 brings the possibility of the United States losing its measles-free status, a status it achieved over two decades ago. This situation is particularly troubling given the nation's substantial investment in artificial intelligence (AI) research and development, with companies like Microsoft, Amazon, Alphabet, and Meta planning to spend between $720 billion and $740 billion on AI infrastructure in 2026.
Despite these advancements in technology, the country is struggling to prevent a disease it had long since eradicated. The Centers for Disease Control and Prevention (CDC) reports a significant increase in measles cases, from just 85 in 2000 to 5,182 confirmed cases by November 5 of 2026, a 61-fold rise. Four deaths have been recorded in the same year.
The paradox of this regression highlights a fundamental issue: while scientific knowledge accumulates, social progress can falter. The measles vaccine remains highly effective, but its success relies on widespread acceptance, a factor that science alone cannot guarantee. Currently, 92.4 percent of American kindergarteners have received the recommended measles, mumps, and rubella (MMR) vaccinations, falling short of the approximately 95 percent coverage needed to prevent outbreaks.
This low vaccination rate, with 280,000 kindergarteners missing doses, underscores the need for public trust in medical interventions. The comparison between AI spending and measles vaccination rates illustrates the different types of investment required for each. AI development demands significant capital and specialized talent, while maintaining measles elimination necessitates millions of small, repeated decisions across diverse communities with varying levels of trust.
While AI can be powerful and backed by substantial investment, its success depends on public trust, which can be more volatile and harder to maintain. The potential of AI to solve major health problems, as discussed by Anthropic CEO Dario Amodei, is contingent upon societal trust in the institutions providing that technology. The decline in trust, whether justified or not, poses a significant risk to the benefits of scientific advancements.
America's struggle with measles eradication serves as a cautionary tale: despite technological prowess, the erosion of social progress can undermine the very benefits it seeks to achieve. The challenge for the AI revolution will not only be in developing more sophisticated machines but also in rebuilding the trust necessary for these innovations to translate into lasting improvements in human health and well-being.
Written by urgent.news from Newsweek's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
